TY - JOUR
T1 - Detection of TS polyomavirus DNA in tonsillar tissues of children and adults
T2 - Evidence for site of viral latency
AU - Sadeghi, Mohammadreza
AU - Aaltonen, Leena Maija
AU - Hedman, Lea
AU - Chen, Tingting
AU - Söderlund-Venermo, Maria
AU - Hedman, Klaus
N1 - Funding Information:
This study was supported by Helsinki University Central Hospital Research & Education and Research & Development funds , the Sigrid Jusélius Foundation , the Academy of Finland , the Helsinki University funds , and the Medical Society of Finland (FLS) .
Funding Information:
We wish to thank Dr. Janet S. Butel from Baylor College of Medicine, Houston, Texas (USA) for providing the RNase P gene plasmids. We thank Dr. Maria Perdomo for reading the manuscript. M.S. expresses his gratitude to the Ministry of Science, Research and Technology of Iran for a research scholarship as well as to Bu-Ali Sina University, Hamedan for the opportunity to advanced studies.
PY - 2014/1
Y1 - 2014/1
N2 - Background: The trichodysplasia spinulosa-associated polyomavirus (TSPyV), a recently discovered species of the family Polyomaviridae, is associated with development of trichodysplasia spinulosa (TS), a rare follicular skin disease of immunocompromised individuals. The viral seroprevalence in the general population is ~70%, with little known of its route of transmission, latency, or primary infection site. Objectives: We aimed to determine whether the viral DNA is detectable in tonsillar tissue of constitutionally healthy individuals, and what the corresponding antiviral seroreactivities are. Study design: We tested 229 matched pairs of tonsillar tissue biopsies and serum samples from asymptomatic donors for TSPyV DNA by real-time quantitative PCR with primer pairs and Taq-Man probes targeting the VP1 and LT genes. The sera were studied by enzyme immunoassay (EIA) for TSPyV-VP1-IgG and the PCR-positive individuals also for -IgM and -IgG-avidity. Results: TSPyV DNA was detectable in 8 (3.5%) of 229 tonsillar tissues, and in none of the corresponding sera. TSPyV IgG seroprevalence among children was 39% and among adults 70%. Each of the 8 PCR-positive subjects had antiviral IgG of high avidity but not IgM. Conclusions: TSPyV PCR positivity of tonsillar samples of individuals with long-term immunity provides the first evidence of TSPyV in tonsils and suggests lymphoid tissue as a latency site of this emerging human pathogen.
AB - Background: The trichodysplasia spinulosa-associated polyomavirus (TSPyV), a recently discovered species of the family Polyomaviridae, is associated with development of trichodysplasia spinulosa (TS), a rare follicular skin disease of immunocompromised individuals. The viral seroprevalence in the general population is ~70%, with little known of its route of transmission, latency, or primary infection site. Objectives: We aimed to determine whether the viral DNA is detectable in tonsillar tissue of constitutionally healthy individuals, and what the corresponding antiviral seroreactivities are. Study design: We tested 229 matched pairs of tonsillar tissue biopsies and serum samples from asymptomatic donors for TSPyV DNA by real-time quantitative PCR with primer pairs and Taq-Man probes targeting the VP1 and LT genes. The sera were studied by enzyme immunoassay (EIA) for TSPyV-VP1-IgG and the PCR-positive individuals also for -IgM and -IgG-avidity. Results: TSPyV DNA was detectable in 8 (3.5%) of 229 tonsillar tissues, and in none of the corresponding sera. TSPyV IgG seroprevalence among children was 39% and among adults 70%. Each of the 8 PCR-positive subjects had antiviral IgG of high avidity but not IgM. Conclusions: TSPyV PCR positivity of tonsillar samples of individuals with long-term immunity provides the first evidence of TSPyV in tonsils and suggests lymphoid tissue as a latency site of this emerging human pathogen.
KW - Persistence
KW - QPCR
KW - RNase P gene
KW - Serology
KW - TS
KW - TSPyV
KW - Tonsil
KW - VLP
UR - http://www.scopus.com/inward/record.url?scp=84891818167&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84891818167&partnerID=8YFLogxK
U2 - 10.1016/j.jcv.2013.11.008
DO - 10.1016/j.jcv.2013.11.008
M3 - Article
C2 - 24315796
AN - SCOPUS:84891818167
SN - 1386-6532
VL - 59
SP - 55
EP - 58
JO - Journal of Clinical Virology
JF - Journal of Clinical Virology
IS - 1
ER -